Design of the vitesse intracranial stent study for ischemic therapy (VISSIT) trial in symptomatic intracranial stenosis

Journal of Stroke and Cerebrovascular Diseases

Volumn 22, Issue 7, 2013, Pages 1131-1139

  Zaidat, Osama O ^a   Castonguay, Alicia C ^a   Fitzsimmons, Brian Fred ^a   Woodward, Britton Keith ^b   Wang, Zhigang ^c   Killer Oberpfalzer, Monika ^d   Wakhloo, Ajay ^e   Gupta, Rishi ^f   Kirshner, Howard ^g   Eliasziw, Misha ^h   Thomas Megerian, J ⁱ   Shetty, Sujith ⁱ   Yoklavich Guilhermier, Meg ⁱ   Barnwell, Stanley ^j   Smith, Wade S ^k   Gress, Daryl R ^l  

^a FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

^b Vista Radiology   (United States)

^c THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^d PARACELSUS MEDICAL UNIVERSITY   (Austria)

^e UNIVERSITY OF MASSACHUSETTS   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^h TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ Research and Development Department of Codman and Shurtleff Inc   (United States)

^j OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l UNIVERSITY OF VIRGINIA   (United States)

more..

Author keywords

angioplasty; balloon mounted stent; clinical trial; endovascular; intracranial stenosis; intracranial stent; ischemic stroke; PHAROS stent; stroke; transient ischemic attack; VISSIT; Vitesse stent

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN;

ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; DEVICE SAFETY; EFFECT SIZE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LOADING DRUG DOSE; METHODOLOGY; NEUROVASCULAR BALLOON EXPANDABLE STENT; OCCLUSIVE CEREBROVASCULAR DISEASE; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA ISCHEMIA; SAMPLE SIZE; STUDY DESIGN; SYMPTOMATIC INTRACRANIAL STENOSIS; TRANSIENT ISCHEMIC ATTACK; VASCULAR STENT;

ANGIOPLASTY; BALLOON-MOUNTED STENT; CLINICAL TRIAL; ENDOVASCULAR; INTRACRANIAL STENOSIS; INTRACRANIAL STENT; ISCHEMIC STROKE; PHAROS STENT; STROKE; TRANSIENT ISCHEMIC ATTACK; VISSIT; VITESSE STENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLINICAL PROTOCOLS; CONSTRICTION, PATHOLOGIC; FEMALE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; MALE; MIDDLE AGED; RESEARCH DESIGN; STENTS; STROKE;

EID: 84886059476     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2012.10.021     Document Type: Article

References (17)

1. P. Gorelick, K. Wong, and H. Bae Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier Stroke 39 2008 2396 2399
2. J.F. Arenillas Intracranial atherosclerosis: current concepts Stroke 42 Suppl 1 2011 S20 S23
3. L.K.S. Wong Global burden of intracranial atherosclerosis Int J Stroke 1 2006 158 159
4. R. Wityk, D. Lehman, and M. Klag Race and sex differences in the distribution of cerebral atherosclerosis Stroke 27 1996 1974 1980
5. R.L. Sacco, D. Kargman, and Q. Gu Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the northern Manhattan stroke study Stroke 26 1995 14 20
6. M.I. Chimowitz, M.J. Lynn, and H. Howlett-Smith Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis N Engl J Med 352 2005 1305 1316
7. S. Kasner, M. Chimowitz, and M. Lynn Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis Circulation 113 2006 555 563
8. M.I. Chimowitz, M.J. Lynn, and T.N. Turan Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial J Stroke Cerebrovasc Dis 20 2011 357 368
9. M.I. Chimowitz, M.J. Lynn, and C.P. Derdeyn Stenting versus aggressive medical therapy for intracranial arterial stenosis N Engl J Med 365 2011 993 1003
10. D. Fiorella, E.I. Levy, and A.S. Turk US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results Stroke 38 2007 881 887
11. O.O. Zaidat, R. Klucznik, and M.J. Alexander The NIH registry on the use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis Neurology 70 2008 1518 1524
12. VISSIT Intracranial Stent Study for Ischemic Therapy. Available at: http://clinicaltrials.gov/ct2/show/NCT00816166. Accessed July27, 2012.
13. H.J. Barnett, D.W. Taylor, and M. Eliasziw Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis N Engl J Med 339 1998 1415 1425
14. J.M. Freitas, M. Zenteno, and Y. Aburto-Murrieta Intracranial arterial stenting for symptomatic stenoses: a Latin American experience Surg Neurol 68 2007 378 386
15. SSYLVIA Study Investigators Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results Stroke 35 2004 1388 1392
16. W.J. Jiang, X.T. Xu, and M. Jin Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results AJNR Am J Neuroradiol 28 2007 830 834
17. A. Bose, M. Hartmann, and H. Henkes A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study Stroke 38 2007 1531 1537